Nephro-Urology Monthly

Published by: Kowsar

The Effect of Vitamin C on Parathyroid Hormone in Patients on Hemodialysis With Secondary Hyperparathyroidism: A Double Blind, Placebo-Controlled Study

Vajihe Biniaz 1 , Eghlim Nemati 2 , Ali Tayebi 1 , * , Mehdi Sadeghi Shermeh 1 and Abbas Ebadi 1
Authors Information
1 Department of Medical Surgical Nursing, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Nephrology and Urology Department, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Nephro-Urology Monthly: November 01, 2013, 5 (5); 962-966
  • Published Online: November 13, 2013
  • Article Type: Research Article
  • Received: May 22, 2013
  • Revised: June 12, 2013
  • Accepted: June 25, 2013
  • DOI: 10.5812/numonthly.12404

To Cite: Biniaz V, Nemati E, Tayebi A, Sadeghi Shermeh M, Ebadi A. The Effect of Vitamin C on Parathyroid Hormone in Patients on Hemodialysis With Secondary Hyperparathyroidism: A Double Blind, Placebo-Controlled Study, Nephro-Urol Mon. 2013 ; 5(5):962-966. doi: 10.5812/numonthly.12404.

Copyright © 2013, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Sanadgol H, Bayani M, Mohammadi M, Bayani B, Mashhadi MA. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism. Iran J Kidney Dis. 2011; 5(6): 410-5[PubMed]
  • 2. Gorriz JL, Molina P, Bover J, Barril G, Martin-de Francisco AL, Caravaca F, et al. Characteristics of bone mineral metabolism in patients with stage 3-5 chronic kidney disease not on dialysis: results of the OSERCE study. Nefrologia. 2013; 33(1): 46-60[DOI][PubMed]
  • 3. Richter A, Kuhlmann MK, Seibert E, Kotanko P, Levin NW, Handelman GJ. Vitamin C deficiency and secondary hyperparathyroidism in chronic haemodialysis patients. Nephrol Dial Transplant. 2008; 23(6): 2058-63[DOI][PubMed]
  • 4. Brossard JH, Lepage R, Cardinal H, Roy L, Rousseau L, Dorais C, et al. Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays. Clin Chem. 2000; 46(5): 697-703[PubMed]
  • 5. Massry SG. Is parathyroid hormone a uremic toxin? Nephron. 1977; 19(3): 125-30[PubMed]
  • 6. Polzin DJ, Osborne CA, Jacob F, Ross S. Textbook of veterinary internal medicine. 2000; : 1634-62
  • 7. Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS, et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol. 2005; 16(6): 1803-10[DOI][PubMed]
  • 8. Martin KJ, Gonzalez EA. Strategies to minimize bone disease in renal failure. Am J Kidney Dis. 2001; 38(6): 1430-6[DOI][PubMed]
  • 9. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001; 12(10): 2131-8[PubMed]
  • 10. Mahdavi-Mazdeh M, Zamyadi M, Norouzi S, Heidary Rouchi A. Management of calcium and phosphorus metabolism in hemodialysis patients in Tehran Province, Iran. Iran J Kidney Dis. 2007; 1(1): 25-8[PubMed]
  • 11. McCauley LK, Koh AJ, Beecher CA, Cui Y, Rosol TJ, Franceschi RT. PTH/PTHrP receptor is temporally regulated during osteoblast differentiation and is associated with collagen synthesis. J Cell Biochem. 1996; 61(4): 638-47[PubMed]
  • 12. Pearce SH, Thakker RV. The calcium-sensing receptor: insights into extracellular calcium homeostasis in health and disease. J Endocrinol. 1997; 154(3): 371-8[PubMed]
  • 13. Deicher R, Ziai F, Bieglmayer C, Schillinger M, Horl WH. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients. J Am Soc Nephrol. 2005; 16(6): 1811-8[DOI][PubMed]
  • 14. Bohm V, Tiroke K, Schneider S, Sperschneider H, Stein G, Bitsch R. Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation. Int J Vitam Nutr Res. 1997; 67(4): 262-6[PubMed]
  • 15. Durose CL, Holdsworth M, Watson V, Przygrodzka F. Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on hemodialysis are not predictive of dietary compliance. J Am Diet Assoc. 2004; 104(1): 35-41[DOI][PubMed]
  • 16. Morena M, Cristol JP, Bosc JY, Tetta C, Forret G, Leger CL, et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant. 2002; 17(3): 422-7[PubMed]
  • 17. Handelman GJ. Vitamin C deficiency in dialysis patients--are we perceiving the tip of an iceberg? Nephrol Dial Transplant. 2007; 22(2): 328-31[DOI][PubMed]
  • 18. Farsi Z. [Rabeteye esteres oksidativ va bimarihaye koleye]. Faslnameye amouzeshie daneshkade parastari-e Bagheyatallah. Educ Quar J Nurs Facult Baghyatalah Univ Med Sci. 2007; 27: 22-3
  • 19. Weissinger EM, Nguyen-Khoa T, Fumeron C, Saltiel C, Walden M, Kaiser T, et al. Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment. Proteomics. 2006; 6(3): 993-1000[DOI][PubMed]
  • 20. Aghazamani M. Renal patients increase 20% yearly. 2011;
  • 21. Dietary Supplement Fact Sheet: Vitamin C.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments